AI-driven drug discovery aided by Greater Bay Area integration, Hong Kong-listed firm says

Quick Summary:

XtalPi says AI is reducing drug discovery times to two years from four.

Zhang said the company’s development has been boosted by regional synergies in the bay area scheme, particularly in talent acquisition, supply chain partnerships and fundraising across cities.

Zhang anticipates that the integration of robotics and AI will reduce drug discovery timelines to just one or two years from four.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Ann Cao

Category: Business

Markets: Hong KongChina

Topics: Greater Artificial Discovery Zhang Xtalpi Industry Drug Area Robotics Development Chief

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2025-01-19 @ 10:30:08 (6 hours ago)

News Timezone: GMT +8:00

News Source URL: scmp.com

Language: English

Article Length: 283 words

Reading Time: 2 minutes read

Sentences: 7 lines

Sentence Length: 41 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © SCMP

News ID: 25243235

View Article Analysis

About SCMP

Main Topics: Business

Official Website: scmp.com

Update Frequency: 4 posts per day

Year Established: 1903

Headquarters: Hong Kong

News Last Updated: 1 hours ago

Coverage Areas: Hong Kong

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #42

Publisher Details

Frequently Asked Questions